Inclusive of all taxes
Glimepiride & Metformin Prolonged Release Tablets IP are a high-quality pharmaceutical formulation designed for the effective management of type 2 diabetes mellitus. This product combines two potent antidiabetic agents, Glimepiride and Metformin, in a prolonged-release tablet form to ensure sustained therapeutic effect and improved patient compliance. Manufactured under stringent WHO-GMP conditions and complying with Indian Pharmacopoeia (IP) standards, these tablets deliver precise dosage and consistent bioavailability, making them highly suitable for both domestic and international markets. The prolonged release mechanism helps maintain steady blood glucose control over an extended period, reducing the frequency of administration and minimizing side effects associated with peak drug concentrations. Packaged in export-grade blister or strip packs, these tablets provide optimal protection from moisture and contamination, ensuring product integrity during transit and storage. Ideal for hospitals, clinics, and pharmaceutical distributors targeting regulated and semi-regulated markets, Glimepiride & Metformin Prolonged Release Tablets IP offer reliable glycemic control backed by high manufacturing and quality assurance standards.
Key Features
| Features | Description |
|---|---|
| Active Ingredients | Glimepiride and Metformin |
| Dosage Form | Prolonged release tablets |
| Indication | Management of type 2 diabetes mellitus |
| Manufacturing Standards | WHO-GMP compliant facilities |
| Pharmacopoeial Compliance | Indian Pharmacopoeia (IP) |
| Packaging | Export-grade blister or strip packs |
| Therapeutic Benefit | Sustained blood glucose control and improved patient compliance |
| Shelf Life | As per regulatory standards |
| Market Suitability | International pharmaceutical markets including regulated and semi-regulated regions |
| Attributes | Description |
|---|---|
| Category | Diabetes medication |
| Formulation Type | Tablet |
| Tablet Type | Prolonged release |
| Manufacturer | IndiGlobal Exports |
| Packaging Material | Blister/strip packs |
| Shelf Life Duration | Defined by exporting country regulatory standards |
| Distribution Suitability | Hospital, retail, and institutional supply |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
The prolonged release formulation ensures a sustained and steady release of Glimepiride and Metformin, maintaining stable blood glucose levels over a longer period and reducing dosing frequency, which improves patient compliance and minimizes side effects.
Yes, the tablets are manufactured in WHO-GMP compliant facilities and meet Indian Pharmacopoeia standards, making them suitable for export to both regulated and semi-regulated pharmaceutical markets.
Glimepiride & Metformin Prolonged Release Tablets IP are available in export-grade blister or strip packs designed to ensure product stability and facilitate convenient shipping and handling.
These tablets are specifically indicated for managing type 2 diabetes mellitus requiring combination therapy of Glimepiride and Metformin for optimal blood glucose control.
Each batch undergoes rigorous quality control and testing according to pharmacopoeial standards and is produced in GMP-compliant manufacturing environments to guarantee dosage uniformity and therapeutic efficacy.
Brand: indiglobal exports
Country Of Origin: India
Glimepiride & Metformin Prolonged release Tablets IP is a pharmaceutical product indicated for diabetes treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Glimepiride & Metformin Prolonged release Tablets IP is developed for the effective management of diabetes conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with diabetes indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
